Ajanta Pharma is a specialty pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.
The company's net profit slumped 19.15% to Rs 122.25 crore in Q4 FY23 as compared with Rs 151.21 crore in Q4 FY22. Revenue from operations increased marginally to Rs 881.84 crore in Q4 FY23 as against Rs 870.29 crore recorded in same quarter last year.